Whois & Analysis for ibrance.com

Palbociclib (codenamed PD-0332991, trade name Ibrance) is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer.

It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

Therapy (often abbreviated tx, Tx, or Tx) is the attempted remediation of a health problem, usually following a diagnosis.

In the medical field, it is usually synonymous with treatment (also abbreviated tx or Tx).

Among psychologists and other mental health professionals, including psychiatrists, psychiatric nurse practitioners, and clinical social workers, the term may refer specifically to psychotherapy (sometimes dubbed 'talking therapy').

The English word therapy comes via Latin therapīa from and literally means "curing" or "healing".

Metastatic breast cancer, also referred to as metastases, advanced breast cancer, secondary tumours, secondaries or stage 4 breast cancer, is a stage of breast cancer where the disease has spread to distant sites beyond the axillary lymph nodes.

There is no cure for metastatic breast cancer.

There is no stage after IV.

Receptor tyrosine-protein kinase erbB-2, also known as CD340 (cluster of differentiation 340), proto-oncogene Neu, Erbb2 (rodent), or ERBB2 (human).

It is a protein that in humans is encoded by the ERBB2 gene, and it is also frequently called HER2 (from human epidermal growth factor receptor 2) or HER2/neu.

In the manufacture of pharmaceuticals, encapsulation refers to a range of dosage forms—techniques used to enclose medicines—in a relatively stable shell known as a capsule, allowing them to, for example, be taken orally or be used as suppositories.

The two main types of capsules are: